Synaptic Modulators (15 results)

Hardcover. Condition: Near Fine. 0306389258. Black cloth hardcover with silver lettering on the spine, from closed pharmaceutical company library. 394 pages, index, illustrated with charts, tables and diagrams. Contents clean, tight and bright. Book.

Paperback. Condition: New.

Condition: New. pp. 396.

Paperback. Condition: Brand New. reprint edition. 393 pages. 10.00x7.00x0.90 inches. In Stock.

Condition: Bon. Merci, votre achat aide à financer des programmes de lutte contre l'illettrisme.

Taschenbuch. Condition: Neu. Synaptic Modulators | Leslie Iversen | Taschenbuch | xii | Englisch | 2012 | Springer | EAN 9781468431797 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - 1 Effects of Drugs on Energy Metabolism of the Brain and on Cerebral Transport.- 1. Introduction.- 2. Drugs and Brain Cell Energetics.- 3. Neurotropic Drugs Affecting Electron and Energy Transfer.- 3.1. Barbiturates.- 3.2. Uncouplers of Brain Respiration.- 3.3. Fluoroacetate.- 3.4. Methionine Sulfoximine.- 3.5. Chlorinated Hydrocarbon Insecticides.- 3.6. 2-Deoxyglucose.- 3.7. -Hydroxybutyrate.- 3.8. Aminooxyacetate.- 3.9. Haloperidol.- 4. Drugs and Brain Cell Permeabilities.- 4.1. Tetrodotoxin.- 4.2. Local Anesthetics: Cocaine, Procaine, Lidocaine, etc.- 4.3. Ouabain.- 4.4. Protoveratrine.- 5. Drugs Affecting Cerebral Biogenic Amine Levels.- 5.1. Reserpine.- 5.2. Phenothiazines.- 5.3. Imipramine.- 5.4. Amphetamines.- 5.5. Monoamine Oxidase Inhibitors.- 5.6. Lysergic Acid Diethylamide (LSD).- 5.7. Amino Acid Decarboxylase Inhibitors.- 6. Ethanol.- 7. References.- 2 Role of Cyclic Nucleotides in the Nervous System.- 1. Introduction.- 2. Enzymatic Formation, Degradation, and Action of Cyclic Nucleotides.- 2.1. Adenylate Cyclases.- 2.2. Guanylate Cyclases.- 2.3. Phosphodiesterases.- 2.4. Protein Kinases.- 2.5. Phosphoprotein Phosphates.- 3. Accumulation of Cyclic Nucleotides.- 3.1. Cyclic AMP in Brain Slices.- 3.2. Cyclic GMP in Brain Slices.- 3.3. Cyclic AMP in Ganglia.- 3.4. Cyclic AMP in Cells of Neuronal or Glial Origin.- 4. Functional Roles of Cyclic Nucleotides.- 4.1. Effects on Enzymatic Processes.- 4.2. Cell Morphology, Differentiation, and Growth.- 4.3. Membrane Phenomena.- 4.4. Centrally Active Drugs and Levels of Cyclic Nucleotides in Brain.- 4.5. Behavioral Effects.- 5. Conclusion.- 6. References.- 3 Purinergic Transmission.- 1. Introduction.- 2. Distribution of Purinergic Nerves.- 2.1. Gastrointestinal Tract.- 2.2. Lung and Trachea.- 2.3. Vascular System.- 2.4. Urinogenital System.- 2.5. Eye.- 2.6. CNS.- 3. Fine Structure and Histochemistry of Purinergic Nerves.- 3.1. Fine Structure of Purinergic Nerves.- 3.2. Histochemical Approaches to Localization of Purinergic Nerves.- 4. Electrophysiology of Purinergic Transmission.- 4.1. Inhibitory Junction Potentials.- 4.2. Postsynaptic Action of Transmitter.- 4.3. Interaction of Purinergic with Cholinergic and Adrenergic Responses in Single Cells.- 5. Physiological Roles of Purinergic Nerves.- 5.1. Reflex Relaxation of the Esophagogastric Junction.- 5.2. żReceptive Relaxationż of the Stomach.- 5.3. żDescending Inhibitionż of Peristalsis.- 5.4. Reflex Relaxation of the Internal Anal Sphincter.- 5.5. Vomiting and Nausea.- 5.6. Bronchodilatation, Asphyxia, Asthma.- 5.7. Coughing.- 5.8. Inflammation of the Skin.- 5.9. Activities in the CNS.- 6. Evidence that ATP is the Purinergic Nerve Transmitter.- 6.1. Formation and Storage of ATP.- 6.2. Release of ATP.- 6.3. Direct Actions of Purine Nucleotides and Nucleosides on Smooth Muscle.- 6.4. Inactivation of ATP.- 6.5. Antagonism and Potentiation of Responses to Nerve Stimulation and ATP.- 7. Pharmacology of Adenyl Compounds and Purinergic Transmission.- 7.1. Inhibitory and Excitatory Action of Adenyl Compounds.- 7.2. Drugs That Antagonize the Action of Adenyl Compounds.- 7.3. Drugs That Potentiate the Action of Adenyl Compounds.- 8. Speculations on the Evolution and Development of Purinergic Nerves.- 9. Summary.- 10. References.- 4 Hypothalamic Hypophysiotropic Hormones.- 1. Introduction.- 2. Hypophysiotropic Hormone Action.- 2.1. Characteristics.- 2.2. Mechanisms of Hypophysiotropic Action of Peripheral Hormones.- 3. Thyrotropin Releasing Factor (TRF).- 3.1. Effect of TRF on Secretion of Other Pituitary Hormones.- 3.2. Psychotropic Actions of TRF.- 3.3. TRF Binding Studies.- 3.4. TRF Structure-Function Relationship Studies.- 4. Luteinizing Hormone Releasing Factor (LRF).- 4.1. LRF Structure-Function Studies.- 4.2. LRF Binding Studies.- 4.3. Behavioral Effects of LRF.- 5. Corticotropin Releasing Factor (CRF).- 6. Prolactin Release Inhibiting Factor (PIF).- 7. Growth Hormone Releasing Factor (GRF).- 8. Somatostatin-Somatotropin Release Inhibiting Factor (SRIF).- 9. References.- 5 Binding, Metabolism, and Action of Steroid Hormones in the Central Nervous System.- 1. Introduction.- 2. Estrogens.- 2.1. Determination of the Estradiol Concentration in Dissected Brain Regions.- 2.2. Determination of the Cellular Localization of [3H]Estradiol by Autoradiography.- 2.3. Subcellular Distribution of Estradiol.- 2.4. Developmental Changes in the Estradiol Binding System.- 2.5. Changes in Estradiol Binding During the Estrus Cycle.- 2.6. Behavioral and Physiological Effects of Estrogen Agonists and Antagonists.- 2.7. Sites of Estrogen Action.- 2.8. Temporal Aspects of Estrogen Action.- 3. Androgens.- 3.1. Regional and Cellular Distribution of Radioactivity After an Injection of [3H]Testosterone in the Castrated Male Rat.- 3.2. Testosterone Metabolism in Peripheral Tissues: The Idea of Testosterone as a żPrehormoneż.- 3.3. Metabolism of Testosterone in the Brain.- 3.4. Saturability and Stereoselectivity of Androgen Retention.- 3.5. Androgen-Binding Macromolecules.- 3.6. Androgen Retention in Birds.- 3.7. Comparison of Sites of Androgen Binding and Androgen Action in the Adult.- 3.8. Androgen Binding and Action During Development.- 3.9. Chemical Specificity of Androgen Action: Is There More Than One Type of Androgen Receptor in the Brain .- 3.10. Role of Aromatization in Androgen Action.- 4. Glucocorticoids.- 4.1. Anatomical Distribution of Corticosterone Binding Sites in the Rat.- 4.2. Saturability and Stereoselectivity of Corticosterone Retention.- 4.3. Subcellular Distribution of Corticosterone.- 4.4. Corticosterone-Binding Macromolecules in the Nucleus and Cytoplasm in Vivo.- 4.5. Corticosterone Binding in Vitro.- 4.6. Experiments on Other Glucocorticoids and Other Species.- 4.7. Metabolism of Glucocorticoids in the Brain.- 4.8. Measurements of Endogenous Glucocorticoids in the Nervous System.- 4.9. Correlations Between Corticosterone Binding and Corticoste.

Condition: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Keine Beschreibung verfügbar.

Condition: new. Questo è un articolo print on demand.

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -1 Effects of Drugs on Energy Metabolism of the Brain and on Cerebral Transport.- 1. Introduction.- 2. Drugs and Brain Cell Energetics.- 3. Neurotropic Drugs Affecting Electron and Energy Transfer.- 3.1. Barbiturates.- 3.2. Uncouplers of Brain Respiration.- 3.3. Fluoroacetate.- 3.4. Methionine Sulfoximine.- 3.5. Chlorinated Hydrocarbon Insecticides.- 3.6. 2-Deoxyglucose.- 3.7. -Hydroxybutyrate.- 3.8. Aminooxyacetate.- 3.9. Haloperidol.- 4. Drugs and Brain Cell Permeabilities.- 4.1. Tetrodotoxin.- 4.2. Local Anesthetics: Cocaine, Procaine, Lidocaine, etc.- 4.3. Ouabain.- 4.4. Protoveratrine.- 5. Drugs Affecting Cerebral Biogenic Amine Levels.- 5.1. Reserpine.- 5.2. Phenothiazines.- 5.3. Imipramine.- 5.4. Amphetamines.- 5.5. Monoamine Oxidase Inhibitors.- 5.6. Lysergic Acid Diethylamide (LSD).- 5.7. Amino Acid Decarboxylase Inhibitors.- 6. Ethanol.- 7. References.- 2 Role of Cyclic Nucleotides in the Nervous System.- 1. Introduction.- 2. Enzymatic Formation, Degradation, and Action of Cyclic Nucleotides.- 2.1. Adenylate Cyclases.- 2.2. Guanylate Cyclases.- 2.3. Phosphodiesterases.- 2.4. Protein Kinases.- 2.5. Phosphoprotein Phosphates.- 3. Accumulation of Cyclic Nucleotides.- 3.1. Cyclic AMP in Brain Slices.- 3.2. Cyclic GMP in Brain Slices.- 3.3. Cyclic AMP in Ganglia.- 3.4. Cyclic AMP in Cells of Neuronal or Glial Origin.- 4. Functional Roles of Cyclic Nucleotides.- 4.1. Effects on Enzymatic Processes.- 4.2. Cell Morphology, Differentiation, and Growth.- 4.3. Membrane Phenomena.- 4.4. Centrally Active Drugs and Levels of Cyclic Nucleotides in Brain.- 4.5. Behavioral Effects.- 5. Conclusion.- 6. References.- 3 Purinergic Transmission.- 1. Introduction.- 2. Distribution of Purinergic Nerves.- 2.1. Gastrointestinal Tract.- 2.2. Lung and Trachea.- 2.3. Vascular System.- 2.4. Urinogenital System.- 2.5. Eye.- 2.6. CNS.- 3. Fine Structure and Histochemistry of Purinergic Nerves.- 3.1. Fine Structure of Purinergic Nerves.- 3.2. Histochemical Approaches to Localization of Purinergic Nerves.- 4. Electrophysiology of Purinergic Transmission.- 4.1. Inhibitory Junction Potentials.- 4.2. Postsynaptic Action of Transmitter.- 4.3. Interaction of Purinergic with Cholinergic and Adrenergic Responses in Single Cells.- 5. Physiological Roles of Purinergic Nerves.- 5.1. Reflex Relaxation of the Esophagogastric Junction.- 5.2. żReceptive Relaxationż of the Stomach.- 5.3. żDescending Inhibitionż of Peristalsis.- 5.4. Reflex Relaxation of the Internal Anal Sphincter.- 5.5. Vomiting and Nausea.- 5.6. Bronchodilatation, Asphyxia, Asthma.- 5.7. Coughing.- 5.8. Inflammation of the Skin.- 5.9. Activities in the CNS.- 6. Evidence that ATP is the Purinergic Nerve Transmitter.- 6.1. Formation and Storage of ATP.- 6.2. Release of ATP.- 6.3. Direct Actions of Purine Nucleotides and Nucleosides on Smooth Muscle.- 6.4. Inactivation of ATP.- 6.5. Antagonism and Potentiation of Responses to Nerve Stimulation and ATP.- 7. Pharmacology of Adenyl Compounds and Purinergic Transmission.- 7.1. Inhibitory and Excitatory Action of Adenyl Compounds.- 7.2. Drugs That Antagonize the Action of Adenyl Compounds.- 7.3. Drugs That Potentiate the Action of Adenyl Compounds.- 8. Speculations on the Evolution and Development of Purinergic Nerves.- 9. Summary.- 10. References.- 4 Hypothalamic Hypophysiotropic Hormones.- 1. Introduction.- 2. Hypophysiotropic Hormone Action.- 2.1. Characteristics.- 2.2. Mechanisms of Hypophysiotropic Action of Peripheral Hormones.- 3. Thyrotropin Releasing Factor (TRF).- 3.1. Effect of TRF on Secretion of Other Pituitary Hormones.- 3.2. Psychotropic Actions of TRF.- 3.3. TRF Binding Studies.- 3.4. TRF Structure-Function Relationship Studies.- 4. Luteinizing Hormone Releasing Factor (LRF).- 4.1. LRF Structure-Function Studies.- 4.2. LRF Binding Studies.- 4.3. Behavioral Effects of LRF.- 5. Corticotropin Releasing Factor (CRF).- 6. Prolactin Release Inhibiting Factor (PIF).- 7. Growth Hormone Releasing Factor (GRF).- 8. Somatostatin-Somatotropin Release Inhibiting Factor (SRIF).- 9. References.- 5 Binding, Metabolism, and Action of Steroid Hormones in the Central Nervous System.- 1. Introduction.- 2. Estrogens.- 2.1. Determination of the Estradiol Concentration in Dissected Brain Regions.- 2.2. Determination of the Cellular Localization of [3H]Estradiol by Autoradiography.- 2.3. Subcellular Distribution of Estradiol.- 2.4. Developmental Changes in the Estradiol Binding System.- 2.5. Changes in Estradiol Binding During the Estrus Cycle.- 2.6. Behavioral and Physiological Effects of Estrogen Agonists and Antagonists.- 2.7. Sites of Estrogen Action.- 2.8. Temporal Aspects of Estrogen Action.- 3. Androgens.- 3.1. Regional and Cellular Distribution of Radioactivity After an Injection of [3H]Testosterone in the Castrated Male Rat.- 3.2. Testosterone Metabolism in Peripheral Tissues: The Idea of Testosterone as a żPrehormoneż.- 3.3. Metabolism of Testosterone in the Brain.- 3.4. Saturability and Stereoselectivity of Androgen Retention.- 3.5. Androgen-Binding Macromolecules.- 3.6. Androgen Retention in Birds.- 3.7. Comparison of Sites of Androgen Binding and Androgen Action in the Adult.- 3.8. Androgen Binding and Action During Development.- 3.9. Chemical Specificity of Androgen Action: Is There More Than One Type of Androgen Receptor in the Brain .- 3.10. Role of Aromatization in Androgen Action.- 4. Glucocorticoids.- 4.1. Anatomical Distribution of Corticosterone Binding Sites in the Rat.- 4.2. Saturability and Stereoselectivity of Corticosterone Retention.- 4.3. Subcellular Distribution of Corticosterone.- 4.4. Corticosterone-Binding Macromolecules in the Nucleus and Cytoplasm in Vivo.- 4.5. Corticosterone Binding in Vitro.- 4.6. Experiments on Other Glucocorticoids and Other Species.- 4.7. Metabolism of Glucocorticoids in the Brain.- 4.8. Measurements of Endogenous Glucocorticoids in the Nervous System.- 4.9. Correlations Between Corticosterone Bindin.

Condition: New. Print on Demand pp. 396 66:B&W 7 x 10 in or 254 x 178 mm Perfect Bound on White w/Gloss Lam.

Paperback / softback. Condition: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.

Condition: New. PRINT ON DEMAND pp. 396.

Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. 1 Effects of Drugs on Energy Metabolism of the Brain and on Cerebral Transport.- 1. Introduction.- 2. Drugs and Brain Cell Energetics.- 3. Neurotropic Drugs Affecting Electron and Energy Transfer.- 3.1. Barbiturates.- 3.2. Uncouplers of Brain Respiration.- .

Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -1 Effects of Drugs on Energy Metabolism of the Brain and on Cerebral Transport.- 1. Introduction.- 2. Drugs and Brain Cell Energetics.- 3. Neurotropic Drugs Affecting Electron and Energy Transfer.- 4. Drugs and Brain Cell Permeabilities.- 5. Drugs Affecting Cerebral Biogenic Amine Levels.- 6. Ethanol.- 7. References.- 2 Role of Cyclic Nucleotides in the Nervous System.- 1. Introduction.- 2. Enzymatic Formation, Degradation, and Action of Cyclic Nucleotides.- 3. Accumulation of Cyclic Nucleotides.- 4. Functional Roles of Cyclic Nucleotides.- 5. Conclusion.- 6. References.- 3 Purinergic Transmission.- 1. Introduction.- 2. Distribution of Purinergic Nerves.- 3. Fine Structure and Histochemistry of Purinergic Nerves.- 4. Electrophysiology of Purinergic Transmission.- 5. Physiological Roles of Purinergic Nerves.- 6. Evidence that ATP is the Purinergic Nerve Transmitter.- 7. Pharmacology of Adenyl Compounds and Purinergic Transmission.- 8. Speculations on the Evolution and Development of Purinergic Nerves.- 9. Summary.- 10. References.- 4 Hypothalamic Hypophysiotropic Hormones.- 1. Introduction.- 2. Hypophysiotropic Hormone Action.- 3. Thyrotropin Releasing Factor (TRF).- 4. Luteinizing Hormone Releasing Factor (LRF).- 5. Corticotropin Releasing Factor (CRF).- 6. Prolactin Release Inhibiting Factor (PIF).- 7. Growth Hormone Releasing Factor (GRF).- 8. Somatostatin-Somatotropin Release Inhibiting Factor (SRIF).- 9. References.- 5 Binding, Metabolism, and Action of Steroid Hormones in the Central Nervous System.- 1. Introduction.- 2. Estrogens.- 3. Androgens.- 4. Glucocorticoids.- 5. Progestins.- 6. Conclusion.- 7. References.- 6 Opiate Receptor Mechanisms.- 1. Introduction.- 2. Biochemical Identification of Opiate-Receptor Binding.- 3. Localization of the Opiate Receptor to Synaptic Membranes.- 4. Regional Distribution of Opiate-Receptor Binding.- 5. Effect of Destruction of Norepinephrine, Serotonin, Acetylcholine, and Dopamine Tracts on Opiate-Receptor Binding.- 6. Phylogenetic Distribution of the Opiate Receptor.- 7. Effect of Sodium on Opiate-Receptor Binding.- 8. Toward a Theory of Addiction.- 9. References.- Addendum to Chapter 2.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 396 pp. Englisch.